Antimalarial Activity of Crambescidin 800 and Synthetic Analogues against Liver and Blood Stage of Plasmodium sp.

Abstract

Structural features associated with the antimalarial activity of the marine natural product crambescidin 800 were studied using synthetic analogues of the related compound ptilomycalin A. The study suggests that the guanidine moiety is cytotoxic, whereas the spermidine-containing aliphatic chain increases activity. The most active analogue, compound 11, had in vitro activity against Plasmodium falciparum strain 3D7 (IC50=490 nM) that was stronger than the in vitro activity against murine L5178Y cells (IC50=8.5~59 μM). In vitro growth inhibition of liver stages of P. yoelii yoelii in mouse hepatocytes was observed (IC50=9.2 μM). The compound did not significantly prolong median survival time after a single subcutaneous administration of 80 mg/kg in P. berghei-infected mice. Compound 11 did not cause DNA fragmentation in an in vitro micronucleus assay.

Author information

Affiliations

Authors

Corresponding author

Correspondence to J Enrico H Lazaro.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lazaro, J., Nitcheu, J., Mahmoudi, N. et al. Antimalarial Activity of Crambescidin 800 and Synthetic Analogues against Liver and Blood Stage of Plasmodium sp.. J Antibiot 59, 583–590 (2006). https://doi.org/10.1038/ja.2006.78

Download citation

Keywords

  • malaria
  • natural product
  • crambescidin
  • Plasmodium

Further reading

Search

Quick links